Heplisav-B Market Report 2026
Download Free Sample Buy Now
Heplisav-B Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Heplisav-B Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Heplisav-B Market Overview

• The Heplisav-B market growth in the historic period has been driven by low compliance with three dose vaccines, rising hepatitis b burden in adults

• Market expansion is supported by expansion of adult vaccination mandates, increasing focus on diabetic and liver disease patients

• Growth Driver: Rising Prevalence Of Hepatitis B Infections Driving Market Growth

• Market Trend: Advancements In Hepatitis B Vaccination

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Heplisav-B Market?

Heplisav-B is a recombinant vaccine designed to protect adults aged 18 and older against hepatitis B. It contains hepatitis B surface antigen (HBsAg) and an advanced adjuvant (1018) to enhance immune response. Administered as a two-dose series over one month, Heplisav-B offers higher seroprotection rates and greater convenience compared to traditional three-dose vaccines, making it particularly effective for high-risk individuals such as healthcare workers, those with chronic liver disease, or people with diabetes.

The main typs of heplisav-B products are vaccines and combination vaccines. Vaccines are biological preparations that provide immunity to a specific infectious disease by stimulating the body's immune system to recognize and fight pathogens. It is used for adult hepatitis b prevention and special populations and is distributed through integrated delivery networks (idns) and large clinics, retail pharmacies, and hospitals.

Heplisav-B Market Global Report 2026 Market Report bar graph

What Is The Heplisav-B Market Size and Share 2026?

The growth in the historic period can be attributed to low compliance with three dose vaccines, rising hepatitis b burden in adults, early adoption in healthcare worker immunization, demand for improved vaccine efficacy, increasing awareness of adult immunization.

What Is The Heplisav-B Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of adult vaccination mandates, increasing focus on diabetic and liver disease patients, wider adoption by integrated delivery networks, growth in employer sponsored vaccination programs, continued emphasis on preventive healthcare. Major trends in the forecast period include two dose adult hepatitis b vaccination adoption, rising preference for high seroprotection vaccines, growth in vaccination among high risk adult populations, shift toward convenience driven immunization schedules, expansion of workplace and occupational vaccination programs.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Heplisav-B Market Segmentation

1) By Product Type: Vaccines, Combination Vaccines

2) By Indication: Adult Hepatitis B Prevention, Special Populations

3) By Distribution Channel: Integrated Delivery Networks (IDNs) And Large Clinics, Retail Pharmacies, Hospitals

What Are The Drivers Of The Heplisav-B Market?

The increasing prevalence of hepatitis B infections is expected to boost the growth of the heplisav-B market going forward. Hepatitis B infections are liver diseases caused by the hepatitis B virus (HBV), which can lead to acute or chronic conditions, including cirrhosis and liver cancer. The prevalence of hepatitis B infections is rising due to low vaccination rates, high-risk group transmission, limited awareness, and inadequate healthcare access. Heplisav-B is a vaccine used to prevent hepatitis B infection by stimulating the immune system to produce protective antibodies. For instance, April 2025, according to Centers for Disease Control and Prevention, U.S-based government agency reported that, in 2023, there were 2,214 new cases of acute hepatitis B reported. Further, there were 1,769 hepatitis B-related deaths reported during 2023. Therefore, the increasing prevalence of hepatitis B infections will drive the growth of the heplisav-B industry.

The rising prevalence of chronic diseases is expected to drive the growth of the heplisav-B market going forward. Chronic disease is a long-term health condition that typically progresses slowly, persists for an extended period, and often requires ongoing medical care and lifestyle management. The rising prevalence of chronic diseases is driven by factors such as aging populations, lifestyle changes, inadequate healthcare access, and increased environmental exposures. Heplisav-b is required for the management of chronic diseases, particularly in individuals with weakened immune systems, as it provides a stronger and longer-lasting immune response to protect against hepatitis B infection. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases will drive the growth of the heplisav-B industry.

Key Players In The Global Heplisav-B Market

Major companies operating in the heplisav-b market are Dynavax Technologies Corporation

Global Heplisav-B Market Trends and Insights

The key trend in the heplisav-B market is focusing on developing innovative products, such as hepatitis b adjuvanted vaccines, to provide stronger and longer-lasting immune responses. A hepatitis B adjuvanted vaccine is an immunization that includes an adjuvant to enhance the body's immune response to the hepatitis B surface antigen, improving vaccine efficacy, especially in populations with weaker immune systems. For instance, in February 2023, Dynavax Technologies Corporation, a US-based biopharmaceutical company, announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Heplisav-B for marketing in Great Britain. This vaccine is designed for adults and is approved for active immunization against all known subtypes of the hepatitis B virus (HBV) in individuals aged 18 years and older. The approval was based on favorable safety and immunogenicity outcomes demonstrated in three Phase 3 clinical trials. Heplisav-B combines the hepatitis B surface antigen with Dynavax's proprietary Toll-like Receptor (TLR) 9 agonist adjuvant, CpG 1018, to enhance the immune response. Dynavax holds the global commercial rights to Heplisav-B.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the heplisav-B market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Heplisav-B Market?

The heplisav-B market consists of sales of adjuvants, immunology products, diagnostic kits, and therapeutic vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Heplisav-B Market Report 2026?

The heplisav-b market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the heplisav-b industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Heplisav-B Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Indication, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Dynavax Technologies Corporation
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Heplisav-B Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Heplisav-B Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Heplisav-B Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Heplisav-B Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Two Dose Adult Hepatitis B Vaccination Adoption

4.2.2 Rising Preference For High Seroprotection Vaccines

4.2.3 Growth In Vaccination Among High Risk Adult Populations

4.2.4 Shift Toward Convenience Driven Immunization Schedules

4.2.5 Expansion Of Workplace And Occupational Vaccination Programs

5. Heplisav-B Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Large Clinics

5.3 Integrated Delivery Networks

5.4 Occupational Health Centers

5.5 Public Health Agencies

6. Heplisav-B Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Heplisav-B Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Heplisav-B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Heplisav-B Market Size, Comparisons And Growth Rate Analysis

7.3. Global Heplisav-B Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Heplisav-B Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Heplisav-B Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Heplisav-B Market Segmentation

9.1. Global Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccines, Combination Vaccines

9.2. Global Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Hepatitis B Prevention, Special Populations

9.3. Global Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Integrated Delivery Networks (IDNs) And Large Clinics, Retail Pharmacies, Hospitals

10. Heplisav-B Market Regional And Country Analysis

10.1. Global Heplisav-B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Heplisav-B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Heplisav-B Market

11.1. Asia-Pacific Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Heplisav-B Market

12.1. China Heplisav-B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Heplisav-B Market

13.1. India Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Heplisav-B Market

14.1. Japan Heplisav-B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Heplisav-B Market

15.1. Australia Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Heplisav-B Market

16.1. South Korea Heplisav-B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Heplisav-B Market

17.1. Western Europe Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Heplisav-B Market

18.1. UK Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Heplisav-B Market

19.1. Germany Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Heplisav-B Market

20.1. France Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Heplisav-B Market

21.1. Eastern Europe Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Heplisav-B Market

22.1. North America Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Heplisav-B Market

23.1. USA Heplisav-B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Heplisav-B Market

24.1. Canada Heplisav-B Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Heplisav-B Market

25.1. South America Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Heplisav-B Market

26.1. Middle East Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Heplisav-B Market

27.1. Africa Heplisav-B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Heplisav-B Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Heplisav-B Market Regulatory and Investment Landscape

29. Heplisav-B Market Competitive Landscape And Company Profiles

29.1. Heplisav-B Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Heplisav-B Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Heplisav-B Market Company Profiles

29.3.1. Dynavax Technologies Corporation Overview, Products and Services, Strategy and Financial Analysis

30. Global Heplisav-B Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Heplisav-B Market

32. Heplisav-B Market High Potential Countries, Segments and Strategies

32.1 Heplisav-B Market In 2030 - Countries Offering Most New Opportunities

32.2 Heplisav-B Market In 2030 - Segments Offering Most New Opportunities

32.3 Heplisav-B Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Heplisav-B Market, Overview Of Key Products - Product Examples
  • Table 2: Global Heplisav-B Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Heplisav-B Market, Supply Chain Analysis
  • Table 4: Global Heplisav-B Market, Major Raw Material Providers
  • Table 5: Global Heplisav-B Market, Major Resource Providers
  • Table 6: Global Heplisav-B Market, Major Manufacturers (Suppliers)
  • Table 7: Global Heplisav-B Market, Major Distributors And Channel Partners
  • Table 8: Global Heplisav-B Market, Key Technologies & Future Trends
  • Table 9: Global Heplisav-B Market, Major Trends
  • Table 10: Global Heplisav-B Market, Major End Users
  • Table 11: Global Heplisav-B Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Heplisav-B Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Heplisav-B Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Heplisav-B Market - TAM, US$ Billion, 2025
  • Table 15: Global Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Heplisav-B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Heplisav-B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Heplisav-B Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Heplisav-B Market - Company Scoring Matrix
  • Table 73: Dynavax Technologies Corporation Financial Performance
  • Table 74: Global Heplisav-B Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Heplisav-B Market, Competitive Dashboard
  • Table 76: Global Heplisav-B Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Heplisav-B Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 78: Global, Heplisav-B Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 79: Global, Heplisav-B Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Heplisav-B Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Heplisav-B Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Heplisav-B Market, Supply Chain Analysis
  • Figure 4: Global Heplisav-B Market, Major Raw Material Providers
  • Figure 5: Global Heplisav-B Market, Major Resource Providers
  • Figure 6: Global Heplisav-B Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Heplisav-B Market, Major Distributors And Channel Partners
  • Figure 8: Global Heplisav-B Market, Key Technologies & Future Trends
  • Figure 9: Global Heplisav-B Market, Major Trends
  • Figure 10: Global Heplisav-B Market, Major End Users
  • Figure 11: Global Heplisav-B Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Heplisav-B Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Heplisav-B Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Heplisav-B Market - TAM, US$ Billion, 2025
  • Figure 15: Global Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Heplisav-B Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Heplisav-B Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Heplisav-B Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Heplisav-B Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Heplisav-B Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Heplisav-B Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Heplisav-B Market - Company Scoring Matrix
  • Figure 73: Dynavax Technologies Corporation Financial Performance
  • Figure 74: Global Heplisav-B Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Heplisav-B Market, Competitive Dashboard
  • Figure 76: Global Heplisav-B Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Heplisav-B Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 78: Global, Heplisav-B Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 79: Global, Heplisav-B Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Cellular Immunotherapy Market Report 2026 - Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Kill...

Oral Biologics & Biosimilar Drugs Market Report 2026 - Global Outlook – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, ...

Biosimilars Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones), By Protein Type (Recombinant Non-glycosylated Proteins, R...

Frequently Asked Questions

The Heplisav-B market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Heplisav-B market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Heplisav-B market Include, Dynavax Technologies Corporation .

Major trend in this market includes: Advancements In Hepatitis B Vaccination. For further insights on this market. request a sample here

North America was the largest region in the heplisav-B market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heplisav-b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us